The Commission funds the Australian Group on Antimicrobial Resistance (AGAR), a component of the Australian Society for Antimicrobials, to:

  • Conduct targeted surveillance of selected pathogens
  • Collect demographic, treatment and outcome data, and data on antimicrobial resistance rates
  • Analyse and report on this data

AGAR is a collaboration of clinicians and scientists from key microbiology laboratories around Australia.

Laboratories participate in the AGAR surveys by providing laboratory data and isolates to the AGAR coordinating laboratories. These AGAR laboratories collate the data, undertake molecular testing on isolates and prepare reports for the following three programs:

  • Gram-negative Sepsis Outcome Program (GNSOP)
  • Staphylococcus aureus Sepsis Outcome Program (ASSOP)
  • Australian Enterococcus Sepsis Outcome Program (AESOP)

AGAR publishes annual reports on the outcomes of these surveys, as well as a range of articles and presentations on findings. For more information on AGAR, please visit the website.

AGAR also prepares reports for the Commission that bring together the key findings of the three sepsis outcome programs, as a means of increasing access to antimicrobial resistance surveillance data to inform response strategies.

Reports are now available for analyses of  2015, 2016 and 2017 AGAR data:

AGAR Sepsis Outcome Programs 2017 report

AGAR Sepsis Outcome Programs 2016 report 

AGAR Sepsis Outcome Programs 2015 report